Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate
✍ Scribed by H. Derendorf; P. Rohdewald; H. Möllmann; J. Rehder; J. Barth; D. Neveling
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 437 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
✦ Synopsis
Prednisolone in the form of its hemisuccinate was given intravenously in two different doses (1200 mg and 75 mg). Plasma levels of the ester and prednisolone were measured and pharmacokinetic parameters were calculated. The results indicate a dose-dependency in the pharmacokinetics of both hemisuccinate and the free alcohol. For the high dose 8 per cent of the administered ester was found unchanged in the urine indicating incomplete conversion of the pro-drug. Comparison with previous studies leads to the conclusion that prednisolone shows doubled non-linear pharmacokinetics with higher total body clearance in the medium dose range than in the low and high dose range. Volume of distribution changes accordingly, but overall elimination rate remains remarkably constant. Saliva levels of prednisolone were low and agree reasonably well with calculated plasma concentrations of free, non-proteinbound prednisolone. No prednisolone hemisuccinate was found in saliva.
📜 SIMILAR VOLUMES
Three simple linear and three simple non-linear pharmacokinetic models are presented which incorporate the reversible metabolism that occurs between prednisone and prednisolone. Under steady-state conditions it is possible to not only distinguish between the linear and non-linear models but also to
Mean minimum quantifiable level (MQL) was 0.01 K g / g . \* No sample.
The protein binding characteristics of prednisone and prednisolone were determined in human and rabbit plasma and in a 4.7 per cent human serum albumin (HSA) solution. The influence of plednisolone on prednisone binding in human plasma was also examined. Prednisolone exhibited nonlinear binding and
The titled compound is a cyclodextrin derivative in which prednisolone 21-succinate (PDsuc) is covalently bound to one of the secondary hydroxyl groups of a-cyclodextrin (a-CyD) via an ester linkage. In this study, the PDsuc-appended a-CyD ester conjugate (PDsuc/a-CyD conjugate) was intracolonically